Vignesh Arasu to Breast Neoplasms
This is a "connection" page, showing publications Vignesh Arasu has written about Breast Neoplasms.
Connection Strength
3.107
-
Fatty Breasts and Palpable Lumps: Diagnostic Mammogram Alone May Be Sufficient to Exclude Cancer. J Breast Imaging. 2026 Jul 28; 8(4):366-375.
Score: 0.560
-
Comparison of Mammography AI Algorithms with a Clinical Risk Model for 5-year Breast Cancer Risk Prediction: An Observational Study. Radiology. 2023 06; 307(5):e222733.
Score: 0.450
-
Response. Radiology. 2013 Feb; 266(2):685-6.
Score: 0.220
-
Benefit of semiannual ipsilateral mammographic surveillance following breast conservation therapy. Radiology. 2012 Aug; 264(2):371-7.
Score: 0.210
-
Can signal enhancement ratio (SER) reduce the number of recommended biopsies without affecting cancer yield in occult MRI-detected lesions? Acad Radiol. 2011 Jun; 18(6):716-21.
Score: 0.193
-
Brief Report: Mammogram Rates Among Women With and Without HIV in a Large Integrated Health Care System. J Acquir Immune Defic Syndr. 2026 Jul 01; 101(7):694-700.
Score: 0.139
-
Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical Trial. JAMA Intern Med. 2026 03 01; 186(3):344-352.
Score: 0.136
-
Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trial. Genome Med. 2025 Aug 28; 17(1):97.
Score: 0.131
-
Examination of fully automated mammographic density measures using LIBRA and breast cancer risk in a cohort of 21,000 non-Hispanic white women. Breast Cancer Res. 2023 08 06; 25(1):92.
Score: 0.114
-
Telehealth for Preoperative Evaluation of Patients With Breast Cancer During the COVID-19 Pandemic. Perm J. 2022 06 29; 26(2):54-63.
Score: 0.105
-
Implementation of Intraoperative Ultrasound Localization for Breast-Conserving Surgery in a Large, Integrated Health Care System is Feasible and Effective. Ann Surg Oncol. 2021 Oct; 28(10):5648-5656.
Score: 0.100
-
Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response. Radiology. 2021 11; 301(2):295-308.
Score: 0.100
-
Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial. Tomography. 2020 06; 6(2):77-85.
Score: 0.091
-
Comparison of Segmentation Methods in Assessing Background Parenchymal Enhancement as a Biomarker for Response to Neoadjuvant Therapy. Tomography. 2020 06; 6(2):101-110.
Score: 0.091
-
Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast Cancer. Tomography. 2020 06; 6(2):216-222.
Score: 0.091
-
Additive value of diffusion-weighted MRI in the I-SPY 2 TRIAL. J Magn Reson Imaging. 2019 12; 50(6):1742-1753.
Score: 0.085
-
Sonographic-MRI Correlation After Percutaneous Sampling of Targeted Breast Ultrasound Lesions: Initial Experiences With Limited-Sequence Unenhanced MRI for Postprocedural Clip Localization. AJR Am J Roentgenol. 2018 Apr; 210(4):927-934.
Score: 0.078
-
Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices. Radiology. 2018 03; 286(3):822-829.
Score: 0.076
-
Inter-reader Variability in the Use of BI-RADS Descriptors for Suspicious Findings on Diagnostic Mammography: A Multi-institution Study of 10 Academic Radiologists. Acad Radiol. 2017 01; 24(1):60-66.
Score: 0.071
-
Lesion morphology on breast MRI affects targeted ultrasound correlation rate. Eur Radiol. 2015 May; 25(5):1279-84.
Score: 0.063